Correlation Between Tscan Therapeutics and Design Therapeutics

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and Design Therapeutics, you can compare the effects of market volatilities on Tscan Therapeutics and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Design Therapeutics.

Diversification Opportunities for Tscan Therapeutics and Design Therapeutics

0.46

Correlation Coefficient

Tscan Therapeutics  Design Therapeutics

Very weak diversification

The 3 months correlation between Tscan and Design is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Design Therapeutics go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Design Therapeutics

Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 1.16 times more return on investment than Design Therapeutics. However, Tscan Therapeutics is 1.16 times more volatile than Design Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Design Therapeutics is currently generating about 0.12 per unit of risk. If you would invest  145.00  in Tscan Therapeutics on May 28, 2025 and sell it today you would earn a total of  42.00  from holding Tscan Therapeutics or generate 28.97% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Tscan Therapeutics  vs.  Design Therapeutics

Tscan Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Tscan Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Tscan Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Design Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Design Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tscan Therapeutics and Design Therapeutics

The main advantage of trading using opposite Tscan Therapeutics and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.

The idea behind Tscan Therapeutics and Design Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.